Skip to content

NHS England announces major new PrEP trial for 2017

Survey finds good knowledge of PrEP in Europe and a considerable amount of unsupported informal PrEP use

There may be fewer people living with undiagnosed HIV in the UK than previously thought

CDC releases new data on HIV diagnosis and prevalence in the United States

Ending the HIV epidemic faces daunting barriers, former WHO HIV chief warns

World Health Organization urges scale-up of HIV self-testing

Health agencies should challenge the idea that most gay men use drugs

Sofosbuvir/ledipasvir is effective for people with HIV/HCV co-infection in real-world clinical practice

Grazoprevir triple regimen demonstrates high cure rates, even for hard-to-treat people

Eric Lawitz, presenting at AASLD 2016. Photo by Liz Highleyman, hivandhepatitis.com